A detailed history of Lgt Financial Advisors LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 1,043 shares of INVA stock, worth $19,869. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,043
Previous 1,043 -0.0%
Holding current value
$19,869
Previous $17.1 Million 17.74%
% of portfolio
0.05%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$12.32 - $16.27 $455 - $601
-37 Reduced 3.43%
1,043 $16.7 Million
Q3 2023

Nov 01, 2023

BUY
$12.37 - $13.89 $13,359 - $15,001
1,080 New
1,080 $14 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.